...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The American Journal of Surgery >Evolution of cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis: are there treatment alternatives?
【24h】

Evolution of cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis: are there treatment alternatives?

机译：细胞减少手术和围手术期腹膜内化疗治疗腹膜癌的演变：有替代治疗方法吗？

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

I read with great interest the article by Chua et al from Sydney, Australia. Especially pertinent was the title of the publication, "Evolution of locoregional treatment for peritoneal carcinomatosis (PC): single-center experience of 308 procedures of cytoreductive surgery (CRS) and periopera-tive intraperitoneal chemotherapy (PIC)." The title is appropriate and the text is true to this title. The development of a new treatment strategy in surgery by evolution has been our most productive methodology. Glasziou et al recognized this fact when they suggested that clinical trials are not always necessary for a new medical technology to be recognized as a standard of care. Quite rightly, Chua et al1 call attention to this fact in their introduction where they discuss the multidisciplinary standard of care for liver metastases from colorectal cancer. Also, the extensive experience in Australia regarding metastasectomy for management of metastatic melanoma was presented.
机译：我非常感兴趣地阅读了澳大利亚悉尼的Chua等人的文章。与出版物标题特别相关的是：“局部区域腹膜癌（PC）治疗的演变：308例细胞减少手术（CRS）和围手术期腹膜内化疗（PIC）的单中心经验”。标题是适当的，文本与该标题相同。通过进化发展一种新的外科手术治疗策略一直是我们最具生产力的方法。当Glasziou等人建议临床试验并非总是被视为一种新的医疗技术作为一种新的医疗技术时，他们就意识到了这一事实。恰如其分，Chua等[1]在引言中引起了人们对这一事实的关注，他们在此讨论了结直肠癌肝转移的多学科护理标准。此外，还介绍了在澳大利亚进行转移性黑色素瘤转移治疗的广泛经验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号